TherapeuticsMD Inc (NYSEMKT:TXMD) Expects To Release TX-004HR In 4Q2017

TherapeuticsMD Inc (NYSEMKT:TXMD) a unique women’s healthcare firm reported fourth quarter and full-year fiscal report for 2016. For the year closed December 2016, net revenue was almost $19.4 million versus almost $20.1 million for the previous year. Net revenue for 4Q2016 was almost $4.5 million as against net revenue of around $5.6 million for the […]

Wall Street Takeaway: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), TherapeuticsMD Inc (NYSEMKT:TXMD), GoPro Inc (NASDAQ:GPRO)

Boston, MA 07/09/2014 (wallstreetpr) – The uncertainty in the biotech sector went down with Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) in the last session, putting it among the most active losers of the day. The stock slumped nearly 4 percent to $6.06 per share. The stock is down more than 11 percent this year. The U.S. biotech […]

TherapeuticsMD Inc (NYSEMKT:TXMD) Announced To Present At 9th Annual JMP Securities Healthcare Conference

Boston, MA 06/18/2014 (wallstreetpr) – TherapeuticsMD Inc (NYSEMKT:TXMD) announced on June 17, 2014 that it will present at Ninth Annual JMP Securities Healthcare Conference. The venue of this Healthcare Conference will be Westin New York Grand Central and it will take place from June 24-25, 2014. TherapeuticsMD Inc’s Co-Founder and Chief Executive Officer, Robert Finizio will […]